Found: 10
Select item for more details and to access through your institution.
Characteristics of Skin Lesions Associated With Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease: A Cohort Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD Patients.
- Published in:
- Journal of Crohn's & Colitis, 2020, v. 14, n. 3, p. 332, doi. 10.1093/ecco-jcc/jjz151
- By:
- Publication type:
- Article
Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort Study.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 11, p. 1401, doi. 10.1093/ecco-jcc/jjz080
- By:
- Publication type:
- Article
Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 7, p. 864, doi. 10.1093/ecco-jcc/jjz008
- By:
- Publication type:
- Article
Vedolizumab Induces Long-term Mucosal Healing in Patients With Crohn's Disease and Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 9, p. 1085, doi. 10.1093/ecco-jcc/jjx048
- By:
- Publication type:
- Article
Tolerability of Shortened Infliximab Infusion Times in Patients With Inflammatory Bowel Diseases: A Single-Center Cohort Study.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2011, v. 106, n. 4, p. 778, doi. 10.1038/ajg.2011.61
- By:
- Publication type:
- Article
A pilot study on the use of the humanized anti–interleukin-2 receptor antibody daclizumab in active ulcerative colitis
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2003, v. 98, n. 2, p. 369, doi. 10.1111/j.1572-0241.2003.07239.x
- By:
- Publication type:
- Article
Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn’s disease
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2002, v. 97, n. 9, p. 2357, doi. 10.1111/j.1572-0241.2002.05991.x
- By:
- Publication type:
- Article
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn’s disease
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2002, v. 97, n. 8, p. 2000, doi. 10.1111/j.1572-0241.2002.05914.x
- By:
- Publication type:
- Article
Etanercept in the Treatment of Active Refractory Crohn's Disease: A Single-Center Pilot Trial.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2001, v. 96, n. 9, p. 2564, doi. 10.1111/j.1572-0241.2001.04705.x
- By:
- Publication type:
- Article